Corvus Pharmaceuticals, Inc. (CRVS)
CRVS Stock Price Chart
Explore Corvus Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze CRVS price movements and trends.
CRVS Company Profile
Discover essential business fundamentals and corporate details for Corvus Pharmaceuticals, Inc. (CRVS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Mar 2016
Employees
31.00
Website
https://www.corvuspharma.comCEO
Richard A. Miller
Description
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm specializing in the development and commercialization of immuno-oncology therapies. Their leading investigational compound, Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, is currently progressing through Phase Ib/II clinical trials for the treatment of non-small cell lung cancer and head and neck cancers. Another promising candidate, CPI-818, functions as a covalent ITK inhibitor. This therapy is undergoing Phase I/Ib clinical evaluation for patients battling various malignant T-cell lymphomas, aiming to impede the proliferation of specific malignant T-cells. Additionally, Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor, is in Phase II clinical trials for individuals diagnosed with either advanced or refractory renal cell carcinoma. Beyond these clinical-stage assets, Corvus maintains a preclinical portfolio including CPI-182, an antibody designed to block inflammation and myeloid suppression, and CPI-935, an adenosine A2B receptor antagonist intended to prevent fibrosis. The company also benefits from a strategic collaboration with Angel Pharmaceuticals, which aids in advancing its diverse pipeline of targeted experimental drugs. Founded in 2014, Corvus Pharmaceuticals is headquartered in Burlingame, California.
CRVS Financial Timeline
Browse a chronological timeline of Corvus Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.17.
Earnings released on 7 May 2026
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%.
Earnings released on 12 Mar 2026
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%.
Earnings released on 4 Nov 2025
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%.
Earnings released on 7 Aug 2025
EPS came in at -$0.10 surpassing the estimated -$0.13 by +23.08%.
Earnings released on 8 May 2025
EPS came in at -$0.13 matching the estimated -$0.13.
Earnings released on 25 Mar 2025
EPS came in at -$0.18 falling short of the estimated -$0.12 by -50.00%.
Earnings released on 12 Nov 2024
EPS came in at -$0.11 matching the estimated -$0.11.
Earnings released on 6 Aug 2024
EPS came in at -$0.07 surpassing the estimated -$0.12 by +41.67%.
Earnings released on 6 May 2024
EPS came in at -$0.12 matching the estimated -$0.12.
Earnings released on 19 Mar 2024
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $246.00k .
Earnings released on 7 Nov 2023
EPS came in at -$0.12 surpassing the estimated -$0.16 by +25.00%.
Earnings released on 8 Aug 2023
EPS came in at -$0.14 matching the estimated -$0.14.
Earnings released on 8 May 2023
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%.
Earnings released on 28 Mar 2023
EPS came in at -$0.21 falling short of the estimated $0.23 by -191.30%.
Earnings released on 3 Nov 2022
EPS came in at -$0.32 falling short of the estimated -$0.16 by -100.00%.
Earnings released on 8 Aug 2022
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%.
Earnings released on 5 May 2022
EPS came in at -$0.18 falling short of the estimated -$0.14 by -28.57%.
Earnings released on 10 Mar 2022
EPS came in at -$0.20 matching the estimated -$0.20.
Earnings released on 1 Nov 2021
EPS came in at -$0.24 surpassing the estimated -$0.30 by +20.00%.
Earnings released on 2 Aug 2021
EPS came in at -$0.28 surpassing the estimated -$0.32 by +12.50%.
CRVS Stock Performance
Access detailed CRVS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
